Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Aug. 5, 2013

View Archived Issues

Chinese regulations could prove to be a boon to exporters

New regulations introduced in July in China, could raise costs for domestic device manufacturers but may prove to be a boon for importers. Read More

Mitek Sports launches new Healix Knotless Anchor

NewCo on the Go: Optimum TAV achieves pre-clinical milestone

Washington roundup: GAO decries self-referral for IMRT; docs say 'misleading'

New Ventures: Harvard Bioscience to separate from its HART subsidiary

Product News:

Washington roundup II: Cardiologists surprised CMS ready to dump INTERMACS

People in the News:

Financings roundup: Truven Health closeson $372M senior note exchange offer

Deals roundup: ICU Medical rumored to be in talks to sell itself to GTCR

Keeping you up to date on recent developments in neurology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...